AWCI
Alpine Woods Capital Investors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $413K | Buy |
8,501
+1,851
| +28% | +$90K | 0.1% | 124 |
|
|
2025
Q1 | $226K | Sell |
6,650
-335
| -5% | -$11.4K | 0.06% | 147 |
|
|
2024
Q4 | $275K | Buy |
6,985
+1,255
| +22% | +$49.4K | 0.05% | 163 |
|
|
2024
Q3 | $314K | Buy |
+5,730
| New | +$314K | 0.06% | 159 |
|
|
2022
Q1 | – | Sell |
-42,766
| Closed | -$3.24M | – | 216 |
|
|
2021
Q4 | $3.24M | Sell |
42,766
-24,900
| -37% | -$1.89M | 0.32% | 98 |
|
|
2021
Q3 | $7.57M | Buy |
67,666
+139
| +0.2% | +$15.6K | 0.81% | 40 |
|
|
2021
Q2 | $10.9M | Buy |
67,527
+27,899
| +70% | +$4.52M | 1.13% | 21 |
|
|
2021
Q1 | $4.83M | Buy |
39,628
+4,434
| +13% | +$540K | 0.54% | 65 |
|
|
2020
Q4 | $5.39M | Buy |
35,194
+6,886
| +24% | +$1.05M | 0.66% | 54 |
|
|
2020
Q3 | $2.37M | Buy |
28,308
+3,262
| +13% | +$273K | 0.36% | 92 |
|
|
2020
Q2 | $1.84M | Buy |
25,046
+10,897
| +77% | +$801K | 0.35% | 86 |
|
|
2020
Q1 | $600K | Buy |
14,149
+4,040
| +40% | +$171K | 0.13% | 151 |
|
|
2019
Q4 | $616K | Sell |
10,109
-49
| -0.5% | -$2.99K | 0.12% | 159 |
|
|
2019
Q3 | $416K | Hold |
10,158
| – | – | 0.08% | 181 |
|
|
2019
Q2 | $478K | Hold |
10,158
| – | – | 0.1% | 186 |
|
|
2019
Q1 | $363K | Hold |
10,158
| – | – | 0.08% | 205 |
|
|
2018
Q4 | $290K | Buy |
10,158
+43
| +0.4% | +$1.23K | 0.07% | 219 |
|
|
2018
Q3 | $449K | Buy |
+10,115
| New | +$449K | 0.09% | 164 |
|